MERGING TRAFFIC — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Continuity BiosciencesAug 2025SEC filingmedium confidence
BiotechBradenton, US
Robert Whitehead(Executive Officer, Director)
Board seatAllen R. Weiss· per SEC Form D · $12M raise · filed Aug 2025
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.